Arif Naqvi, the founder of Abraaj Capital. Dubai's Shuaa Capital is among a growing list of companies declaring exposure to Abraaj. courtesy World Economic Forum
Arif Naqvi, the founder of Abraaj Capital. Dubai's Shuaa Capital is among a growing list of companies declaring exposure to Abraaj. courtesy World Economic Forum

Abraaj's Naqvi relinquishes control of funds business in major organisational shakeup



Arif Naqvi, the founder of the Middle Easts’ biggest private equity investor Abraaj Group, is relinquishing control of the firm's fund management business in a reshuffle following allegations funds earmarked for healthcare projects in the developing world were misused.

Abraaj, which was founded in 2002 and has about $13.6 billion of assets under management on Friday announced broad changes to the firm’s governance and operating model, appointing of a new leadership team, which it said is aimed at boosting performance through “governance and accountability”.

Omar Lodhi and Selcuk Yorgancioglu, the two partners with the firm, have been promoted as co-chief executives of the fund management business, Abraaj Investment Management Limited (AIML), which will have an independent board of directors.

The reorganisation follows Abraaj coming under fire in recent weeks after US media reported that some of the 24 investors in the Abraaj Growth Markets Health Fund (AGHF), hired forensic accountants to investigate the possible misuse of money invested in the fund. The concerned investors include Bill & Melinda Gates Foundation, the World Bank’s International Finance Corporation, Britain’s CDC Group and Proparco Group of France.

Abraaj dismissed the reports as “inaccurate and misleading” and said unused capital in AGHF was returned in December following discussions with investors. On February 8 the company said that a KPMG review of the firm’s health fund found no misuse of funds.

Mr Naqvi declined to comment when reached by The National.

_________________

Read More:

Abraaj says KPMG review finds no evidence of fund misuse

Abraaj denies misappropriating healthcare funds

Abraaj enters Tunisian market with a stake in Tunisie Telecom

_________________

As part of the reorganisation drive, AIML has commissioned a review of its corporate structure with focus on governance and control functions. It has hired independent consultants for the job.

Given the breadth of structural and management changes and ongoing review, Abraaj has decided to temporarily suspend deployment of capital, other than on the transactions for which commitments are already final, it said without the specifying how long the suspension will remain in effect.

“This has in no way slowed Abraaj’s momentum in deal sourcing and transaction negotiations that are performed by investment teams across its markets,” according to the statement.

Mr Lodhi and Mr Yorgancioglu are assuming their new roles with immediate effect.  Both have been with the firm for over 10 years and were respectively partners for the Abraaj Group’s Asia and Turkey businesses. The fund management business will continue to oversee the operations of all of Abraaj’s funds globally on behalf of institutional investors.

Mr Naqvi will remain chief executive of Abraaj Holdings and will retain a non-executive role as a member of global investment committee of AIML.

“This transition allows me to dedicate more time to developing new platforms that can strengthen the compact between business and society,” Mr Naqvi said.

In the last 16 years the Dubai-based firm has expanded in regions including Asia, Africa, the Middle East, Turkey and Latin America. Only 17 per cent of Abraaj’s portfolio is now in the Middle East, Naqvi said at a conference in November.

The company has a stake in Tunisie Telecom which it purchased from the telecoms investment unit of Dubai Holding in December. Abraaj is bullish on prospects of investing in Saudi Arabia and may acquire assets in the Arab world's biggest economy, as the kingdom continues to encourage foreign investments, Mr Naqvi told The National in October.

Need to know

When: October 17 until November 10

Cost: Entry is free but some events require prior registration

Where: Various locations including National Theatre (Abu Dhabi), Abu Dhabi Cultural Center, Zayed University Promenade, Beach Rotana (Abu Dhabi), Vox Cinemas at Yas Mall, Sharjah Youth Center

What: The Korea Festival will feature art exhibitions, a B-boy dance show, a mini K-pop concert, traditional dance and music performances, food tastings, a beauty seminar, and more.

For more information: www.koreafestivaluae.com

In-demand jobs and monthly salaries
  • Technology expert in robotics and automation: Dh20,000 to Dh40,000 
  • Energy engineer: Dh25,000 to Dh30,000 
  • Production engineer: Dh30,000 to Dh40,000 
  • Data-driven supply chain management professional: Dh30,000 to Dh50,000 
  • HR leader: Dh40,000 to Dh60,000 
  • Engineering leader: Dh30,000 to Dh55,000 
  • Project manager: Dh55,000 to Dh65,000 
  • Senior reservoir engineer: Dh40,000 to Dh55,000 
  • Senior drilling engineer: Dh38,000 to Dh46,000 
  • Senior process engineer: Dh28,000 to Dh38,000 
  • Senior maintenance engineer: Dh22,000 to Dh34,000 
  • Field engineer: Dh6,500 to Dh7,500
  • Field supervisor: Dh9,000 to Dh12,000
  • Field operator: Dh5,000 to Dh7,000
Sinopharm vaccine explained

The Sinopharm vaccine was created using techniques that have been around for decades. 

“This is an inactivated vaccine. Simply what it means is that the virus is taken, cultured and inactivated," said Dr Nawal Al Kaabi, chair of the UAE's National Covid-19 Clinical Management Committee.

"What is left is a skeleton of the virus so it looks like a virus, but it is not live."

This is then injected into the body.

"The body will recognise it and form antibodies but because it is inactive, we will need more than one dose. The body will not develop immunity with one dose," she said.

"You have to be exposed more than one time to what we call the antigen."

The vaccine should offer protection for at least months, but no one knows how long beyond that.

Dr Al Kaabi said early vaccine volunteers in China were given shots last spring and still have antibodies today.

“Since it is inactivated, it will not last forever," she said.

Company Profile 

Founder: Omar Onsi

Launched: 2018

Employees: 35

Financing stage: Seed round ($12 million)

Investors: B&Y, Phoenician Funds, M1 Group, Shorooq Partners

%3Cp%3E%3Cstrong%3EDirector%3A%3C%2Fstrong%3E%20Nag%20Ashwin%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EStarring%3A%20%3C%2Fstrong%3EPrabhas%2C%20Saswata%20Chatterjee%2C%20Deepika%20Padukone%2C%20Amitabh%20Bachchan%2C%20Shobhana%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3ERating%3A%20%3C%2Fstrong%3E%E2%98%85%E2%98%85%E2%98%85%E2%98%85%3C%2Fp%3E%0A
Vidaamuyarchi

Director: Magizh Thirumeni

Stars: Ajith Kumar, Arjun Sarja, Trisha Krishnan, Regina Cassandra

Rating: 4/5

 

COMPANY PROFILE

Company: Bidzi

● Started: 2024

● Founders: Akshay Dosaj and Asif Rashid

● Based: Dubai, UAE

● Industry: M&A

● Funding size: Bootstrapped

● No of employees: Nine

Understand What Black Is

The Last Poets

(Studio Rockers)